HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (49) Citing Articles via Google Scholar Google Scholar Articles by Keire, D. A. Articles by Reeve, J. R. Search for Related Content PubMed PubMed Citation Articles by Keire, D. A. Articles by Reeve, J. R., Jr.

Vol. 279, Issue 1, G126-G131, July 2000

Primary structures of PYY, [Pro³⁴]PYY, and PYY-(3-36) confer different conformations and receptor selectivity

David A. Keire¹, Peter Mannon², Mitsuo Kobayashi¹, John H. Walsh^,3,4, Travis E. Solomon^3,4, and Joseph R. Reeve Jr.^3,4

¹ The Beckman Research Institute of the City of Hope, Duarte, California, 91010-0269; ² Durham Veterans Affairs and Duke University Medical Centers, Durham, North Carolina, 27705; ³ CURE Digestive Diseases Research Center, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles 90073; and ⁴ Digestive Diseases Division, UCLA School of Medicine, Los Angeles, California 90095

We synthesized PYY-(1-36) (nonselective between Y₁ and Y₂ receptor subtype agonists), [Pro³⁴]PYY (selective for Y₁), and PYY-(3-36) (selective for Y₂) to determine whether solution conformation plays a role in receptor subtype selectivity. The three peptides exhibited the expected specificities in displacing labeled PYY-(1-36) from cells transfected with Y₁ receptors (dissociation constants = 0.42, 0.21, and 1,050 nM, respectively) and from cells transfected with Y₂ receptors (dissociation constants = 0.03, 710, and 0.11 nM, respectively) for PYY-(1-36), [Pro³⁴]PYY, and PYY-(3-36). Sedimentation equilibrium analyses revealed that the three PYY analogs were 80-90% monomer at the concentrations used for the subsequent circular dichroism (CD) and ¹H-nuclear magnetic resonance (NMR) studies. CD analysis measured helicities for PYY-(1-36), [Pro³⁴]PYY, and PYY-(3-36) of 42%, 31%, and 24%, suggesting distinct differences in secondary structure. The backbone ¹H-NMR resonances of the three peptides further substantiated marked conformational differences. These patterns support the hypothesis that Y₁ and Y₂ receptor subtype binding affinities depend on the secondary and tertiary solution state structures of PYY and its analogs.

peptide YY; Y₁ receptor; Y₂ receptor; circular dichroism; nuclear magnetic resonance; three-dimensional structure

---

 Deceased 14 June 2000.

This article has been cited by other articles:

				S. Hao, C. Sternini, and H. E. Raybould Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R33 - R38. [Abstract] [Full Text] [PDF]

				K J Oliveira, G S M Paula, R H Costa-e-Sousa, L L Souza, D C Moraes, F H Curty, and C C Pazos-Moura Peptide YY (PYY)3-36 modulates thyrotropin secretion in rats. J. Endocrinol., November 1, 2006; 191(2): 459 - 463. [Abstract] [Full Text] [PDF]

				L. Pinilla, R. Fernandez-Fernandez, E. Vigo, V. M. Navarro, J. Roa, J. M. Castellano, R. Pineda, M. Tena-Sempere, and E. Aguilar Stimulatory effect of PYY-(3-36) on gonadotropin secretion is potentiated in fasted rats Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1162 - E1171. [Abstract] [Full Text] [PDF]

				N. Ahituv, N. Kavaslar, W. Schackwitz, A. Ustaszewska, J. M. Collier, S. Hebert, H. Doelle, R. Dent, L. A. Pennacchio, and R. McPherson A PYY Q62P variant linked to human obesity Hum. Mol. Genet., February 1, 2006; 15(3): 387 - 391. [Abstract] [Full Text] [PDF]

				S. Schonhoff, L. Baggio, C. Ratineau, S. K. Ray, J. Lindner, M. A. Magnuson, D. J. Drucker, and A. B. Leiter Energy Homeostasis and Gastrointestinal Endocrine Differentiation Do Not Require the Anorectic Hormone Peptide YY Mol. Cell. Biol., May 15, 2005; 25(10): 4189 - 4199. [Abstract] [Full Text] [PDF]

				T. H. Moran, U. Smedh, K. P. Kinzig, K. A. Scott, S. Knipp, and E. E. Ladenheim Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R384 - R388. [Abstract] [Full Text] [PDF]

				P. K. Chelikani, A. C. Haver, and R. D. Reidelberger Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1064 - R1070. [Abstract] [Full Text] [PDF]

				C.-C. Connie Hung, F. Pirie, J. Luan, E. Lank, A. Motala, G. S.H. Yeo, J. M. Keogh, N. J. Wareham, S. O'Rahilly, and I. S. Farooqi Studies of the Peptide YY and Neuropeptide Y2 Receptor Genes in Relation to Human Obesity and Obesity-Related Traits Diabetes, September 1, 2004; 53(9): 2461 - 2466. [Abstract] [Full Text] [PDF]

				N. Shimba, A. M. Nomura, A. B. Marnett, and C. S. Craik Herpesvirus Protease Inhibition by Dimer Disruption J. Virol., June 15, 2004; 78(12): 6657 - 6665. [Abstract] [Full Text] [PDF]

				N M Neary, C J Small, and S R Bloom Gut and mind Gut, July 1, 2003; 52(7): 918 - 921. [Abstract] [Full Text]

				V. Audinot, P. Beauverger, C. Lahaye, T. Suply, M. Rodriguez, C. Ouvry, V. Lamamy, J. Imbert, H. Rique, J.-L. Nahon, et al. Structure-Activity Relationship Studies of Melanin-concentrating Hormone (MCH)-related Peptide Ligands at SLC-1, the Human MCH Receptor J. Biol. Chem., April 20, 2001; 276(17): 13554 - 13562. [Abstract] [Full Text] [PDF]